Banking Group Pushes Congress for Cannabis Finance Reform
ABA urges lawmakers to pass SAFE Banking Act, citing public safety and illicit finance concerns as cannabis companies struggle with limited banking access.
The American Bankers Association has formally pressed Congress to advance the SAFE Banking Act, arguing that continued banking restrictions on cannabis businesses create public safety risks and hamper efforts to combat illegal financial activity. The trade group's intervention adds institutional weight to legislative efforts that have stalled despite bipartisan support.
Naomi Camper, the ABA's chief policy officer, frames the banking restrictions as counterproductive to law enforcement goals, noting that cash-heavy cannabis operations complicate regulatory oversight and create opportunities for money laundering. The association's position reflects growing frustration among financial institutions caught between state-legal cannabis markets and federal banking regulations that treat marijuana businesses as high-risk clients.
The SAFE Banking Act would provide legal protections for banks serving state-licensed cannabis companies, potentially unlocking access to traditional financial services including business loans, payment processing, and standard banking relationships. Current federal restrictions force many cannabis operators to conduct business primarily in cash, creating security vulnerabilities and limiting growth capital options.
Cannabis companies across major markets including California, Colorado, and New York continue operating with limited banking relationships, constraining operational efficiency and institutional investment flows. Multi-state operators like Curaleaf, Green Thumb Industries, and Trulieve have built substantial revenue bases despite these banking limitations, but institutional capital remains largely sidelined pending federal reform.
The ABA's advocacy comes as cannabis banking reform faces renewed legislative momentum, with industry observers viewing financial sector support as critical for advancing federal policy changes. Banking normalization would likely accelerate institutional investment in cannabis markets and improve operational metrics across publicly traded cannabis companies, though timing for congressional action remains uncertain given competing legislative priorities.